GLYPICAN-3 ENRICHED IN EXOSOMES NOT IN THE MICROVESICLES: A POTENTIAL BIOMARKER FOR HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Koksal, Ali Riza [1 ,2 ]
Aydin, Yucel [3 ,4 ]
Lin, Dong [3 ]
Nunez, Kelley [5 ]
Thevenot, Paul [6 ]
Parsi, Mansour A. [2 ]
Cohen, Ari J. [6 ]
Dash, Srikanta [3 ]
机构：
[1] Sisli Hamidiye Etfal Educ & Res Hosp, Dept Gastroenterol & Hepatol, Istanbul, Turkey
[2] Tulane Univ, Sch Med, Gastroenterol & Hepatol, New Orleans, LA 70118 USA
[3] Tulane Univ, Hlth Sci Ctr, Pathol & Lab Med, New Orleans, LA 70118 USA
[4] St Marys Hosp, Internal Med, St Louis, MO USA
[5] Ochsner Hlth Syst, Translat Res, Jefferson, AR USA
[6] Ochsner Hlth Syst, Jefferson, AR USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1146
引用
收藏
页码：691A / 692A
页数：2
相关论文
共 50 条
  • [1] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Yao, Min
    Pan, Liu-Hong
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 122 - 123
  • [2] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Min Yao
    Liu-Hong Pan
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 122 - 123
  • [3] Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes Not in the Microvesicles
    Koksal, Ali Riza
    Thevenot, Paul
    Aydin, Yucel
    Nunez, Kelley
    Sandow, Tyler
    Widmer, Kyle
    Nayak, Leela
    Scott, John
    Delk, Molly
    Moehlen, Martin W.
    Cohen, Ari J.
    Dash, Srikanta
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 959 - 972
  • [4] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (04) : 361 - 366
  • [5] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [6] Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
    Fu, Shun-Jun
    Qi, Chao-Ying
    Xiao, Wei-Kai
    Li, Shao-Qiang
    Peng, Bao-Gang
    Liang, Li-Jian
    SURGERY, 2013, 154 (03) : 536 - 544
  • [7] Gene Expression of Hepatocellular Carcinoma Reveals Glypican-3 Role as Potential Biomarker
    Nastase, Anca
    Bacalbasa, Nicolae
    Ilie, Veronica
    Florea, Raluca
    Sorop, Andrei
    Tica, Valeria
    Paslaru, Liliana
    Iacob, Razvan
    Grigorie, Razvan
    Herlea, Vlad
    Dima, Simona
    Popescu, Irinel
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2014, 19 (05): : 9657 - 9665
  • [8] Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
    Zhou, Fubo
    Shang, Wenting
    Yu, Xiaoling
    Tian, Jie
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (02) : 741 - 767
  • [9] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [10] Glypican-3 as a Potential Therapeutic Target for Hepatocellular Carcinoma Immunotherapy
    Trinh, Thu
    Liu, Chen
    FASEB JOURNAL, 2012, 26
12345